PEGylated Magnetite/Hydroxyapatite: A Green Nanocomposite for T2-Weighted MRI and Curcumin Carrying

Figure 6

MTT cell viability results for (a) A549 and (b) MCF-7 cancer cells and (c) MRC-5 normal cells treated with different concentrations of MHA, PMHA, CUR@MHA, CUR@PMHA, and free curcumin at 24 h. All data were reported as the mean ± SD (n = 4).

(a)

(b)

(c)